News

Bavarian Nordic will scale up and is targeting to manufacture more than 1 million doses of the prophylactic vaccine in 2015 for clinical trials and emergency use in the current Ebola outbreak in West Africa.

Findings strengthen link between specific brain region and normal memory decline Dietary cocoa flavanols- naturally occurring bioactives found in cocoa- reversed age-related memory decline in healthy older adults, according to a study led by Columbia University Medical Center (CUMC) scientists.

Proof-of-concept study highlights new therapeutic use of engineered human stem cells Harvard Stem Cell Institute scientists at Massachusetts General Hospital have devised a new way to use stem cells in the fight against brain cancer.

New investigation methods using functional magnetic resonance tomography (fMRT) offer insights into fetal brain development. These "in vivo" observations will uncover different stages of the brain's development.

Digoxin, a medication used in the treatment of heart failure, may be adaptable for the treatment of amyotrophic lateral sclerosis (ALS)  suggests new research at Washington University School of Medicine in St.

An enzyme key to DNA repair can worsen tissue damage caused by stroke and organ transplantation.

Scientists used self-assembly under controlled conditions to create a membrane consisting of layers with distinctly different structures.

A test could help doctors diagnose sepsis and begin treatment earlier.

Contract awarded for the development of patient-derived stem cells in gear-up for age-related macular degeneration trial.

“Best Collaboration” and “Best Technology Application — Upstream” Awards acknowledges ambr250 mini bioreactor system as an exceptional technology.